Related Experiment Video
Updated: Mar 25, 2026

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
MALAT1 long ncRNA promotes gastric cancer metastasis by suppressing PCDH10
Ying Qi1, Hong Sain Ooi2, Jun Wu3
1School of Biomedical Engineering, Bio-ID Research Center, State Key Laboratory for Oncogenes and Related Genes, Shanghai Jiao Tong University, Shanghai, China.
Abstract:
EZH2, the catalytic component of polycomb repressive complex 2 (PRC2), is frequently overexpressed in human cancers and contributes to tumor initiation and progression, in part through transcriptional silencing of tumor suppressor genes. A number of noncoding RNAs (ncRNAs) recruit EZH2 to specific chromatin loci, where they modulate gene expression. Here, we used RNA immunoprecipitation sequencing (RIP-seq) to profile EZH2-associated transcripts in human gastric cancer cell lines. We identified 8,256 transcripts, including both noncoding and coding transcripts, some of which were derived from cancer-related loci. In particular, we found that long noncoding RNA (lncRNA) MALAT1 binds EZH2, suppresses the tumor suppressor PCDH10, and promotes gastric cellular migration and invasion. Our work thus provides a global view of the EZH2-associated transcriptome and offers new insight into the function of EZH2 in gastric tumorigenesis.
Insights
This study reveals that enhancer of zeste homolog 2 (EZH2) binds many transcripts in gastric cancer cells. The long noncoding RNA MALAT1 was found to promote cancer progression by interacting with EZH2.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Enhancer of zeste homolog 2 (EZH2) is a key component of polycomb repressive complex 2 (PRC2).
- EZH2 overexpression is common in human cancers, driving tumor initiation and progression via gene silencing.
- Noncoding RNAs (ncRNAs) are known to recruit EZH2 to specific genomic sites, influencing gene expression.
Purpose of the Study:
- To globally profile EZH2-associated transcripts in human gastric cancer.
- To identify novel roles of EZH2 and its interacting RNAs in gastric tumorigenesis.
- To investigate the specific function of the long noncoding RNA MALAT1 in EZH2-mediated cancer progression.
Main Methods:
- RNA immunoprecipitation sequencing (RIP-seq) was employed to identify EZH2-bound transcripts.
- Gastric cancer cell lines were used for transcriptomic profiling.
- Functional assays were performed to assess the impact of MALAT1-EZH2 interaction on cancer cell behavior.
Main Results:
- Over 8,000 EZH2-associated transcripts were identified, including coding and noncoding RNAs.
- The long noncoding RNA MALAT1 was confirmed to bind EZH2.
- MALAT1 was shown to suppress the tumor suppressor PCDH10, enhancing gastric cancer cell migration and invasion.
Conclusions:
- This study provides a comprehensive map of the EZH2-associated transcriptome in gastric cancer.
- EZH2 plays a significant role in gastric tumorigenesis through interactions with various transcripts.
- The lncRNA MALAT1-EZH2 axis represents a potential therapeutic target for gastric cancer.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Abnormal Proliferation
Non-LTR Retrotransposons
